14h
The Healthy on MSNA Cold, Sinus and Allergy Product Sold at Walmart and Other Retailers Has Been Recalled NationwideWith respiratory illnesses still circulating, this is a reminder why it's essential to follow best practice with this type of ...
It's allergy season in Arizona. Here's everything to know, including what is causing your allergies, common seasonal allergy ...
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted ... medication for patients with severe allergic reactions and other life-threatening ...
A nasal vaccine for COVID-19—based on technology ... The trial will be conducted by the National Institute of Allergy and Infectious Diseases (NIAID), of the National Institutes of Health ...
But it’s not a new phenomenon. The first damning reports of ‘addiction’ to decongestant nasal sprays date back to the early 1980s, when scientists linked the drugs to psychosis, paranoia ...
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more ...
Research suggests that introducing kids to food allergens early in life can help—but that the same might not be true for other types of allergies. Here's what to know. Studies have suggested ...
A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.
She is a member of the Executive Committee for the National Allergy Centre of Excellence (NACE), which is supported by funding from the Australian government. She was a named investigator on a ...
Study reveals how immune cells in the gut distinguish between food and harmful pathogens, shedding light on the origins of both food allergies and intestinal diseases. With every bite of food we ...
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results